Always look on the bright side of life. In today's statement the company states that sales of Bioeffective A are up 83% on the December quarter. So far as I can see from the "Appendix 4C - quarterly" of 31 Jan, receipts from customers for the December quarter were $52,000. Assuming all these receipts came from sales of Bioeffective A, sales this quarter were $95,000. As I said a few days ago, I bet these sales could be increased even more if they did a Blackmores and put Bioeffective A on the shelves.
On the dark side - on 31st January the company announced that it "has 25,887,633 Unlisted Options exercisable at $0.20 that expire on 30 April, 2008. The Directors anticipate the Company receiving a further $5,177,546 from the exercise of these options."
Given what has happened over the last few days, I wonder whether this estimated total needs to be revised downwards.
SLA Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)